These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35643798)

  • 41. Catheter ablation of ventricular tachycardia in patients with prior cardiac surgery: An analysis from the International VT Ablation Center Collaborative Group.
    Aguilar M; Tedrow UB; Tzou WS; Tung R; Frankel DS; Santangeli P; Vaseghi M; Bunch TJ; Di Biase L; Tholakanahalli VN; Lakkireddy D; Dickfeld T; Weiss JP; Mathuria N; Vergara P; Nakahara S; Bradfield JS; Burkhardt JD; Stevenson WG; Callans DJ; Della Bella P; Natale A; Shivkumar K; Marchlinski FE; Sauer WH
    J Cardiovasc Electrophysiol; 2021 Feb; 32(2):409-416. PubMed ID: 33355965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Substrate-modification using electroanatomical mapping in sinus rhythm to treat ventricular tachycardia in patients with ischemic cardiomyopathy.
    Deneke T; Grewe PH; Lawo T; Calcum B; Mügge A; Lemke B
    Z Kardiol; 2005 Jul; 94(7):453-60. PubMed ID: 15997346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of Number of Oral Antiarrhythmic Drug Failures Before Referral on Outcomes Following Catheter Ablation of Ventricular Tachycardia.
    Romero J; Stevenson WG; Fujii A; Kapur S; Baldinger SH; Mehta NK; John RM; Michaud GF; Epstein LM; Koplan BA; Tedrow UB; Kumar S
    JACC Clin Electrophysiol; 2018 Jun; 4(6):810-819. PubMed ID: 29929675
    [TBL] [Abstract][Full Text] [Related]  

  • 44. First-line ablation of ventricular tachycardia in ischemic cardiomyopathy: stratification of outcomes by left ventricular function.
    Briceño DF; Romero J; Patel K; Liaqat W; Zhang XD; Alviz I; Yang R; Rodriguez D; Lakkireddy D; Rocca DD; Tarantino N; Gopinathannair R; Natale A; Di Biase L
    J Interv Card Electrophysiol; 2021 Nov; 62(2):391-400. PubMed ID: 33179155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multicenter Experience With Catheter Ablation for Ventricular Tachycardia in Lamin A/C Cardiomyopathy.
    Kumar S; Androulakis AF; Sellal JM; Maury P; Gandjbakhch E; Waintraub X; Rollin A; Richard P; Charron P; Baldinger SH; Macintyre CJ; Koplan BA; John RM; Michaud GF; Zeppenfeld K; Sacher F; Lakdawala NK; Stevenson WG; Tedrow UB
    Circ Arrhythm Electrophysiol; 2016 Aug; 9(8):. PubMed ID: 27506821
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined endo- and epicardial pace-mapping to localize ventricular tachycardia isthmus in ischaemic and non-ischaemic cardiomyopathy.
    Hanaki Y; Komatsu Y; Nogami A; Kowase S; Kurosaki K; Sekiguchi Y; Aonuma K; Ieda M
    Europace; 2022 Apr; 24(4):587-597. PubMed ID: 34543395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early Versus Late Referral for Catheter Ablation of Ventricular Tachycardia in Patients With Structural Heart Disease: A Systematic Review and Meta-Analysis of Clinical Outcomes.
    Romero J; Di Biase L; Diaz JC; Quispe R; Du X; Briceno D; Avendano R; Tedrow U; John RM; Michaud GF; Natale A; Stevenson WG; Kumar S
    JACC Clin Electrophysiol; 2018 Mar; 4(3):374-382. PubMed ID: 30089564
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia.
    Komatsu Y; Daly M; Sacher F; Cochet H; Denis A; Derval N; Jesel L; Zellerhoff S; Lim HS; Jadidi A; Nault I; Shah A; Roten L; Pascale P; Scherr D; Aurillac-Lavignolle V; Hocini M; Haïssaguerre M; Jaïs P
    J Am Coll Cardiol; 2014 Apr; 63(14):1416-26. PubMed ID: 24486269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy: A propensity score-matched analysis of in-hospital outcomes in the United States.
    Briceño DF; Gupta T; Romero J; Kolte D; Khera S; Villablanca PA; Tran A; Mohanty S; Trivedi C; Mohanty P; Gianni C; Kim SG; Garcia M; Fonarow GC; Bhatt DL; Natale A; Di Biase L
    J Cardiovasc Electrophysiol; 2018 May; 29(5):771-779. PubMed ID: 29399923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-density substrate-guided ventricular tachycardia ablation: role of activation mapping in an attempt to improve procedural effectiveness.
    Carbucicchio C; Ahmad Raja N; Di Biase L; Volpe V; Dello Russo A; Trivedi C; Bartoletti S; Zucchetti M; Casella M; Russo E; Santangeli P; Moltrasio M; Tundo F; Fassini G; Natale A; Tondo C
    Heart Rhythm; 2013 Dec; 10(12):1850-8. PubMed ID: 24055940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. VT Recurrence After Ablation: Incomplete Ablation or Disease Progression? A Multicentric European Study.
    Berte B; Sacher F; Venlet J; Andreu D; Mahida S; Aldhoon B; DE Potter T; Sarkozy A; Tavernier R; Andronache M; Deneke T; Kautzner J; Berruezo A; Cochet H; Zeppenfeld K; Jaïs P
    J Cardiovasc Electrophysiol; 2016 Jan; 27(1):80-7. PubMed ID: 26471955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term benefit of first-line peri-implantable cardioverter-defibrillator implant ventricular tachycardia-substrate ablation in secondary prevention patients.
    Acosta J; Cabanelas N; Penela D; Fernández-Armenta J; Andreu D; Borràs R; Korshunov V; Cabrera M; Vasanelli F; Arbelo E; Guasch E; Martínez M; Tolosana JM; Mont L; Berruezo A
    Europace; 2017 Jun; 19(6):976-982. PubMed ID: 27353322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Substrate-Based Ablation Versus Ablation Guided by Activation and Entrainment Mapping for Ventricular Tachycardia: A Systematic Review and Meta-Analysis.
    Kumar S; Baldinger SH; Romero J; Fujii A; Mahida SN; Tedrow UB; Stevenson WG
    J Cardiovasc Electrophysiol; 2016 Dec; 27(12):1437-1447. PubMed ID: 27574120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A systematic review and meta-analysis comparing radiofrequency catheter ablation with medical therapy for ventricular tachycardia in patients with ischemic and non-ischemic cardiomyopathies.
    Ravi V; Poudyal A; Khanal S; Khalil C; Vij A; Sanders D; Larsen T; Trohman RG; Aksu T; Tung R; Santangeli P; Winterfield J; Sharma PS; Huang HD
    J Interv Card Electrophysiol; 2023 Jan; 66(1):161-175. PubMed ID: 35759160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ventricular Tachycardia Ablation in Patients With Desmoplakin Cardiomyopathy.
    Ghannam M; Liang JJ; Hoogendoorn J; Zeppenfeld K; Siontis KC; Asirvatham SJ; Sacher F; Maury P; Gandjbakhch E; Morady F; Bogun F
    JACC Clin Electrophysiol; 2024 Mar; 10(3):502-511. PubMed ID: 38206261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Catheter ablation of scar based ventricular tachycardia - Procedural characteristics and outcomes.
    Yadav A; Ramasamy S; Theodore J; Anantharaj A; Pillai AA; Satheesh S; Selvaraj RJ
    Indian Heart J; 2020; 72(6):563-569. PubMed ID: 33357646
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Catheter ablation as first-line treatment for ventricular tachycardia in patients with structural heart disease and preserved left ventricular ejection fraction: a systematic review and meta-analysis.
    Askarinejad A; Arya A; Zangiabadian M; Ghahramanipour Z; Hesami H; Farmani D; Ghanbari Mardasi K; Kohansal E; Haghjoo M
    Sci Rep; 2024 Aug; 14(1):18536. PubMed ID: 39122752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of repeat ablation of ventricular tachycardia in patients with structural heart disease.
    Garcia Garcia J; Arya A; Dinov B; Bollmann A; Ter Bekke RMA; Vernooy K; Dagres N; Hindricks G; Darma A
    Europace; 2023 Dec; 26(1):. PubMed ID: 38127308
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute and long-term outcomes of VT radiofrequency catheter ablation in patients with versus without an intramural septal substrate.
    Halbfass P; Ludwig D; Sonne K; Nentwich K; Ene E; Berkovitz A; Foldyna B; Barth S; Müller J; Lehmkuhl L; Lüsebrink U; Waechter C; Deneke T
    Indian Pacing Electrophysiol J; 2022; 22(1):2-9. PubMed ID: 34655759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Prospective, Multicentre Randomised Controlled Trial Comparing Catheter Ablation Versus Antiarrhythmic Drugs in Patients With Structural Heart Disease Related Ventricular Tachycardia: The CAAD-VT Trial Protocol.
    ; Bennett RG; Campbell T; Garikapati K; Kotake Y; Turnbull S; Kanawati J; Wong MS; Qian P; Thomas SP; Chow CK; Kovoor P; Robert Denniss A; Chik W; Marschner S; Kistler P; Haqqani H; Rowe M; Voskoboinik A; Lee G; Jackson N; Sanders P; Roberts-Thomson K; Chan KH; Sy R; Pathak R; Kanagaratnam L; Chia K; El-Sokkari I; Hallani H; Kanthan A; Burgess D; Kumar S
    Heart Lung Circ; 2023 Feb; 32(2):184-196. PubMed ID: 36599791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.